Sustained release griseofulvin / Targeting Ref-1 protein with APX3330 drug as new treatments for AMD
Автор: Macular Degeneration Foundation
Загружено: 2023-09-20
Просмотров: 94
Timothy Corson, Ph.D.
Indiana University School of Medicine
Chair, Department of Pharmacology & Toxicology
https://medicine.iu.edu/
(317) 274-3305
[email protected]
Sustained release griseofulvin microparticles offer long-term therapy for
choroidal neovascularization in a preclinical model Also, Targeting Ref-1 protein with APX3330 drug is possible oral treatment for AMD
#AMD #maculardegeneration #griseofulvin #apx3330 #indianauniversity #timcorson #choroidalneovascularization #clinicaltrials
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: